Changes in hepatitis C virus antibody titer and viral RNA load in non‐Hodgkin’s lymphoma patients after rituximab chemotherapy

Y Tsutsumi,K Ichiki,J Tanaka,T Kawamura,N Masauzi,M Asaka,M Imamura,S Shiratori

doi:10.1111/j.1751-553x.2008.01034.x

Y Tsutsumi, K Ichiki + Show 6 more

Open Access

https://doi.org/10.1111/j.1751-553x.2008.01034.x

Copy DOI

Abstract

Changes in hepatitis C virus antibody titer and viral RNA load in non‐Hodgkin’s lymphoma patients after rituximab chemotherapy

Highlights

Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation
The HCV-RNA load increased gradually elevated after the administration of R-CHO or R-THP-CO (THP-COP without predonisolone)
We previously reported changes in the titers of antibodies to HBsAg and to hepatitis B core antigen that were due to treatment with chemotherapy and rituximab (Tsutsumi et al, 2005)

Summary

Introduction

Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. R-CHO (CHOP without predonisolone) and was decreased after the administration of CHO (without rituximab). The HCV-RNA load was elevated only after the administration of rituximab. The HCV-RNA load increased gradually elevated after the administration of R-CHO or R-THP-CO (THP-COP without predonisolone).

Results

Conclusion